Hydrocortisone rapidly and significantly reduces the IL-6 level in blood and lungs of patients with COVID-19-related ARDS

Crit Care. 2024 Mar 28;28(1):101. doi: 10.1186/s13054-024-04887-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19* / complications
  • Humans
  • Hydrocortisone / therapeutic use
  • Interleukin-6
  • Lung
  • Respiratory Distress Syndrome* / drug therapy

Substances

  • Interleukin-6
  • Hydrocortisone